<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04593836</url>
  </required_header>
  <id_info>
    <org_study_id>V101A-002</org_study_id>
    <nct_id>NCT04593836</nct_id>
  </id_info>
  <brief_title>Antiperistaltic Effect and Safety of L-menthol in the Elderly With Contraindication to Buscopan</brief_title>
  <acronym>Non-Buscopan</acronym>
  <official_title>Antiperistaltic Effect and Safety of L-menthol and Placebo for Upper GI Endoscopy in the Elderly With Contraindication to Buscopan: a Prospective, Randomized, Double-blind Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Taipei Veterans General Hospital, Taiwan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Taipei Veterans General Hospital, Taiwan</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      antiperistaltic effect and safety of L-menthol versus placebo for upper GI endoscopy in&#xD;
      elderly patient with contraindication to Buscopan: randomized study&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Endoscopy is a important tool for diagnosis and treatment of gastrointestinal diseases.&#xD;
      Effective inhibition of gastrointestinal motility during examination is important to achieve&#xD;
      good results and quality.&#xD;
&#xD;
      Traditionally, hyoscine-N-butylbromide (Buscopan) is the most commonly used drugs that&#xD;
      inhibit intestinal peristalsis. But the side effects of drugs were mentioned in many studies,&#xD;
      such as arrhythmia, increased glaucoma, dysuria in patients who have benign prostatic&#xD;
      hypertrophy and allergic reactions, and may even cause anaphylactic shock. Peppermint oil is&#xD;
      the extract of the natural plant (Mentha X piperita L) which was growth in North America and&#xD;
      Europe. L-menthol is main component of peppermint oil. In animal experiments, peppermint oil&#xD;
      had effect of calcium channel blockers and cause gastrointestinal smooth muscle relaxing&#xD;
      effect. Clinically, peppermint oil preparations were used to relieve stress headache,&#xD;
      non-ulcer dyspepsia and irritable bowel syndrome. The oral or intestinal local spraying of&#xD;
      peppermint oil or L-menthol showed inhibition of intestinal peristalsis in many studies, and&#xD;
      improved colonoscopy, barium enema, retrograde cholangiography , and upper gastrointestinal&#xD;
      endoscopy examination.&#xD;
&#xD;
      With the aging of the population of Taiwan and the universality of endoscopy for elderly&#xD;
      patients, the safety of endoscopy in elderly patients has more and more attention. According&#xD;
      to ASGA guidelines, age is not a contraindication for endoscopy. But 50% of elderly patients&#xD;
      have contraindications for hyoscine-N-butylbromide use. Therefore, effort to find alternative&#xD;
      medicine to improve quality of endoscopy in elderly patients is necessary. Therefore, the&#xD;
      investigators design a research for comparing effect and safety of L-menthol and placebo in&#xD;
      elderly patients who have contraindication of hyoscine-N-butylbromide.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 2012</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Peristaltic grade</measure>
    <time_frame>10 mins</time_frame>
    <description>Grade 1: no peristalsis; grade 2: mild peristalsis; grade 3: moderate peristalsis; grade 4: vigorous peristalsis; grade 5: markedly vigorous peristalsis.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pylorus contraction ratio</measure>
    <time_frame>3 mins</time_frame>
    <description>Contraction ratio (%)= [(maximal pyloric ring diameter - minimal pyloric ring diameter)/minimal pyloric ring diameter] x 100</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pylorus opening ratio: maximum and minimum</measure>
    <time_frame>3 mins</time_frame>
    <description>Opening ratio (%) = [(pyloric ring diameter after administration of the antispasmodic agent - pyloric ring diameter before administration of the antispasmodic agent) / pyloric ring diameter before administration of the antispasmodic agent] x 100</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse effect of patients</measure>
    <time_frame>48 hours</time_frame>
    <description>record all adverse effect after study, include abdominal pain, heart burn, headache, allergy, etc.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>VAS score of patient about procedure</measure>
    <time_frame>10 mins</time_frame>
    <description>VAS score 1-10 about the painful sensation of patient during procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Satisfaction of endoscopist</measure>
    <time_frame>10 mins</time_frame>
    <description>Four score was evaluated: very easy, easy, slightly difficult and difficult about the procedure due to gastric spasm</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Upper Gastrointestinal Endoscopy</condition>
  <arm_group>
    <arm_group_label>L-menthol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>20ml 0.8% L-menthol spray on the pyloric ring and observe the gastric peristalsis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>20ml 0.8% placebo spray on the pyloric ring and observe the gastric peristalsis</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>L-menthol</intervention_name>
    <description>20ml 0.8% L-menthol spray on the pyloric ring and observe the gastric peristalsis</description>
    <arm_group_label>L-menthol</arm_group_label>
    <other_name>Peppermint oil</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>20ml 0.8% placebo spray on the pyloric ring and observe the gastric peristalsis</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>Olive oil</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  &gt;65 years old&#xD;
&#xD;
          -  routine endoscopic examination&#xD;
&#xD;
          -  Contraindication to Buscopan(such as arrhythmia, glaucoma, benign prostatic&#xD;
             hyperplasia, ischemic heart disease...)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Status post gastric or duodenal surgery&#xD;
&#xD;
          -  The patient with critical illness are not suitable for the endoscopic examination&#xD;
&#xD;
          -  Upper gastrointestinal bleeding&#xD;
&#xD;
          -  Gastric tumor&#xD;
&#xD;
          -  Gastric or duodenal ulcers are larger than 2 cm&#xD;
&#xD;
          -  Severe pyloric obstruction or deformity&#xD;
&#xD;
          -  Cancer patients received chemotherapy or radiation therapy&#xD;
&#xD;
          -  Had peppermint allergy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ming-Chih Hou, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Taipei Veterans General Hospital, Taiwan</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ming-Chih Hou, MD</last_name>
    <phone>886-2-28712121</phone>
    <phone_ext>1320</phone_ext>
    <email>mchou@vghtpe.gov.tw</email>
  </overall_contact>
  <location>
    <facility>
      <name>Taipei Veterans General Hospital</name>
      <address>
        <city>Taipei</city>
        <zip>11217</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ming-Chih Hou, MD</last_name>
      <phone>886-2-28712121</phone>
      <phone_ext>1320</phone_ext>
      <email>mchou@vghtpe.gov.tw</email>
    </contact>
    <contact_backup>
      <last_name>Han-Chieh Lin, MD</last_name>
      <phone>886-2-28712121</phone>
      <phone_ext>7506</phone_ext>
      <email>hclin@vghtpe.gov.tw</email>
    </contact_backup>
    <investigator>
      <last_name>Ming-Chih Hou, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>October 22, 2013</study_first_submitted>
  <study_first_submitted_qc>October 13, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 20, 2020</study_first_posted>
  <last_update_submitted>October 13, 2020</last_update_submitted>
  <last_update_submitted_qc>October 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Upper gastrointestinal endoscopy</keyword>
  <keyword>Peppermint oil</keyword>
  <keyword>L-menthol</keyword>
  <keyword>Elderly</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Peppermint oil</mesh_term>
    <mesh_term>Menthol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

